Dietary supplements are a $380 billion industry worldwide, but it’s hard to know which ones we truly need, especially during ...

Store in a cool, dry place. The most common side effects of naltrexone are listed below. Tell your healthcare provider if you have any of these side effects that bother you. There may be other ...

A study found that reducing the dose of pembrolizumab in patients with advanced stage non–small cell lung cancer did not significantly affect overall survival compared to the standard dose. One-year ...

It’s a prescription stimulant approved by the Food and Drug Administration (FDA) for treating ADHD or narcolepsy. The effects of the medication can be positive when Adderall is taken as intended ...

In a statement to PEOPLE, Takeda Pharmaceuticals, the maker of Vyvanse, said: "Takeda believes it is important for patients to take our medicines in accordance with U.S. Food and Drug ...

Monkeys that received metformin daily showed slower age-associated brain decline than did those not given the drug. Furthermore, their neuronal activity resembled that of monkeys about six years ...

The two ongoing Phase 3 studies (NCT06350890, NCT06415773), fully enrolled in 2Q 2024, evaluate the efficacy and safety of HTD1801 in T2DM patients (as monotherapy or in combination with metformin ...

1:45 Research sheds light on mpox vaccine effectiveness in real world outbreak A single dose of the mpox vaccine offers moderate protection against the virus, according to a new Canadian study.

Welcome to Sportstar’s live blog of the FIFA World Cup 2026 CONMEBOL qualifier match between Paraguay and Brazil. Stay Tuned for all news and updates from the game at Asunción, Paraguay.

Berberine ursodeoxycholate (HTD1801), the company’s lead drug candidate, received Fast Track designation from the U.S. FDA for both NASH and PSC, as well as Orphan Drug designation for PSC.

HONG KONG, Sept 11, 2024 - () - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for ...